alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Order filed October 27, 2020 

In The

Fourteenth Court of Appeals

____________

NO. 14-20-00506-CV

____________

IN THE INTEREST OF S.B., A CHILD

On Appeal from the 314th District Court

Harris County, Texas

Trial Court Cause No. 2019-68803

O R D E R

The brief of appellants, J.B. and D.B., was due October 19, 2020. No brief 

or motion for extension of time has been filed. Unless appellants file a brief with

this court on or before November 18, 2020, the court will dismiss the appeal for 

want of prosecution. See Tex. R. App. P. 42.3(b). 

PER CURIAM

Panel consists of Justices Christopher, Jewell, and Zimmerer.
JESSIE CLYDE KELLEY

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 16

- 1714

____ _________________________/

Opinion filed November 9, 2016.

An appeal from an order of the Circuit Court for Bay County

. James B. Fensom , Judge

.

Nancy A. Daniels, Public Defender, and Steven L. Seliger, Assistant Public

Defender, Tallahassee , for Appella nt; Jessie Clyde Kelley, pro se, Appellant.

Pamela Jo Bondi

, Attorney General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

B.L. THOMAS, WETHERELL, and M.K. THOMAS, JJ., CONCUR.
<PAGE>


                                                                      Exhibit 23

INDEPENDENT AUDITORS' CONSENT



To Intelligroup, Inc.:

         We consent to the incorporation by reference in Intelligroup, Inc.'s
(the "Company") Registration Statement File Nos. 333-11486, 333-31809,
333-56143, 333-67583, 333-73051, 333-94285 and 333-70244 of our report dated
March 29, 2004, appearing in the Annual Report on Form 10-K of the Company for
the year ended December 31, 2003.



                                                     /s/ DELOITTE & TOUCHE LLP

Parsippany, New Jersey
March 29, 2004
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2193 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2193

 To amend title 38, United States Code, to modify authorities relating 
   to the collective bargaining of employees in the Veterans Health 
                            Administration.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 30, 2015

Mr. Takano (for himself, Mr. Pocan, Miss Rice of New York, Mr. Schiff, 
Mr. Van Hollen, Mr. Cooper, and Mr. Grijalva) introduced the following 
     bill; which was referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
 To amend title 38, United States Code, to modify authorities relating 
   to the collective bargaining of employees in the Veterans Health 
                            Administration.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``VA Employee Fairness Act of 2015''.

SEC. 2. MODIFICATION OF AUTHORITIES ON COLLECTIVE BARGAINING OF 
              EMPLOYEES OF THE VETERANS HEALTH ADMINISTRATION.

    Section 7422 of title 38, United States Code, is amended--
            (1) by striking subsections (b), (c), and (d); and
            (2) by redesignating subsection (e) as subsection (b).
                                 <all>
```
Listen

# Commission Business Meetings

The Commission meets monthly to conduct agency business on civil rights matters. Pursuant to the Sunshine Act, meetings of official business of the U.S. Commission on Civil Rights are open to the public, apart from executive sessions, which may be closed pursuant to the exemptions of the Sunshine Act.

People with disabilities are always encouraged to attend Commission meetings. Those who plan to attend a meeting and require accommodations should notify USCCR via email to access@usccr.gov, as soon as possible to allow time to make arrangements.

Hearing-impaired persons who wish to attend a meeting and require the services of a sign language interpreter should contact Pamela Dunston at (202) 376-8105 or at signlanguage@usccr.gov at least seven business days before the scheduled date of the meeting.

If you require additional information on any commission meeting please contact:

Angelia RorisonDirector of Media and Communications(202) 376-8371

View Commission business meeting dates for 2024 as passed by majority vote of USCCR Commissioners.

Commission Business Meeting
Event Date: June 16, 2023

Commission Business Meeting
Event Date: May 18, 2023

Commission Business Meeting
Event Date: April 21, 2023

Commission Business Meeting CANCELED
Event Date: February 10, 2023

Commission Business Meeting CANCELED
Event Date: December 9, 2022

-    First  
-    Previous  
-  1 
-  2 
-  3 
-   ...  
-   Next  
-   Last  

-  Event Calendar 
-  Public Briefings 
-  Commission Business Meetings 
-  Advisory Committees Meetings 
-  Archives
##### 



Exhibit 32.2
 Visual Networks, Inc.
 Written Statement of Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  (a)
    
    the Quarterly Report on Form 10-Q of the Company for the quarter ended September
30, 2005 filed on the date hereof with the Securities and Exchange Commission (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(b)
    
    information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 /s/ Donald E. ClarkeDonald E. ClarkeExecutive Vice President and ChiefFinancial OfficerNovember 9, 2005
<TABLE> <S> <C>

<ARTICLE> 5 <LEGEND>
This schedule contains summary financial information extracted from SEC Form
10-K dated December 31, 1996 and is qualified in its entirety by reference to
such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> DEUTSCHE MARK
       
<S>                                        <C>          <C>
<PERIOD-TYPE>                                    6-MOS       12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996  DEC-31-1996
<PERIOD-START>                             JAN-01-1996  JAN-01-1996
<PERIOD-END>                               JUN-30-1996  DEC-31-1996
<EXCHANGE-RATE>                                  1.521       1.5387
<CASH>                                          10,172          951
<SECURITIES>                                         0            0
<RECEIVABLES>                                    2,855        3,246
<ALLOWANCES>                                         0            0
<INVENTORY>                                      1,497        1,811
<CURRENT-ASSETS>                                     0            0
<PP&E>                                         232,797      230,341
<DEPRECIATION>                                       0            0
<TOTAL-ASSETS>                                 428,011      422,032
<CURRENT-LIABILITIES>                           41,538       40,522
<BONDS>                                        246,644      274,306
<PREFERRED-MANDATORY>                                0            0
<PREFERRED>                                          0            0
<COMMON>                                           100       10,000
<OTHER-SE>                                     139,256       97,112
<TOTAL-LIABILITY-AND-EQUITY>                   428,011      422,032
<SALES>                                              0            0
<TOTAL-REVENUES>                                31,062       64,422
<CGS>                                                0            0
<TOTAL-COSTS>                                   14,828       31,069
<OTHER-EXPENSES>                                22,391       49,714
<LOSS-PROVISION>                                     0            0
<INTEREST-EXPENSE>                              18,563       31,134
<INCOME-PRETAX>                                (24,711)     (51,313)    
<INCOME-TAX>                                       126         (546)
<INCOME-CONTINUING>                                  0            0
<DISCONTINUED>                                       0            0
<EXTRAORDINARY>                                      0        5,322
<CHANGES>                                            0            0
<NET-INCOME>                                   (24,837)     (57,181)
<EPS-PRIMARY>                                        0            0
<EPS-DILUTED>                                        0            0
        


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF THRIFT MANAGEMENT, INC. FOR THE TWELVE MONTHS ENDED
DECEMBER 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       2,202,540
<SECURITIES>                                         0
<RECEIVABLES>                                  189,688
<ALLOWANCES>                                         0
<INVENTORY>                                    328,433
<CURRENT-ASSETS>                             2,720,661
<PP&E>                                         636,116
<DEPRECIATION>                                 169,882
<TOTAL-ASSETS>                               3,411,487
<CURRENT-LIABILITIES>                          382,162
<BONDS>                                          5,052
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      2,500
<COMMON>                                        21,450
<OTHER-SE>                                   3,000,323
<TOTAL-LIABILITY-AND-EQUITY>                 3,411,487
<SALES>                                      7,728,241
<TOTAL-REVENUES>                             7,728,241
<CGS>                                        3,951,016
<TOTAL-COSTS>                                3,951,016
<OTHER-EXPENSES>                             3,447,983
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,365
<INCOME-PRETAX>                                425,942
<INCOME-TAX>                                   162,000
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   263,942
<EPS-PRIMARY>                                      .12
<EPS-DILUTED>                                      .12
        

</TABLE>
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM








We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-121601, 333-144155 and 333-149855) of Integrated BioPharma, Inc., of our reports, dated October 13, 2011 relating to the consolidated financial statements as of June 30, 2011 and June 30, 2010 and the fiscal years then ended, which is included in this Form 10-K filing, which reports expresses an unqualified opinion and includes an explanatory paragraph relating to the ability of Integrated BioPharma, Inc. to continue as a going concern.

















East Hanover, New Jersey


October 13, 2011
```

[Federal Register Volume 86, Number 178 (Friday, September 17, 2021)]
[Notices]
[Page 51908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20186]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Initial Review Group Genome Research Study Section.
    Date: November 4-5, 2021.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 3100, Bethesda, 
MD 20892, (Virtual Meeting).
    Contact Person: Keith McKenney, Ph.D., Scientific Review 
Officer, National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 3100, Bethesda, 
MD 20817, 301-594-4280, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: September 14, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20186 Filed 9-16-21; 8:45 am]
BILLING CODE 4140-01-P
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Veterans Affairs

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App. 2, that a virtual meeting of the Advisory Committee on Disability Compensation (Committee), which was previously scheduled for Tuesday, September 28, 2021; has been rescheduled to begin and end on Tuesday, November 9, 2021 from 9:00 a.m. to 12:00 p.m. Eastern Standard Time. The virtual meeting is open to the public.

The purpose of the Committee is to advise the Secretary of Veterans Affairs on the maintenance and periodic readjustment of the VA Schedule for Rating Disabilities.

The Committee is to assemble and review relevant information relating to the nature and character of disabilities arising during service in the Armed Forces, provide an ongoing assessment of the effectiveness of the rating schedule, and give advice on the most appropriate means of responding to the needs of Veterans relating to disability compensation.

The agenda will include review and discussion of the 2020 Biennial Report and report recommendation training.

                    No time will be allocated at this virtual meeting for receiving oral presentations from the public.  The public may submit 1-2 page summaries of their written statements for the Committee's review. Public comments may be received no later than October 26, 2021, for inclusion in the official meeting record. Please send these comments to Sian Roussel of the Veterans Benefits Administration, Compensation Service at                     *sian.roussel@va.gov.*

                    Members of the public who wish to obtain a copy of the agenda should contact Sian Roussel at                     *Sian.Roussel@va.gov*                     and provide his/her name, professional affiliation, email address and phone number. The call-in number for those who would like to attend the meeting is 1-404-397-1596; access code: 199 738 1753.                

Dated: September 14, 2021.

Jelessa M. Burney,

Federal Advisory Committee Management Officer.

[FR Doc. 2021-20206 Filed 9-17-21; 8:45 am]

BILLING CODE P
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0001018749
<NAME> OCEAN VISTA LAND COMPANY
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               9,060,498
<CURRENT-LIABILITIES>                            4,416
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                    200,000
<COMMON>                                       350,000
<OTHER-SE>                                   8,162,378
<TOTAL-LIABILITY-AND-EQUITY>                 9,060,498
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Cite as 2015 Ark. App. 528

ARKANSAS COURT OF APPEALS

DIVISION II

No. CV-15-466

O.M.

APPELLANT

V.

ARKANSAS DEPARTMENT OF

HUMAN SERVICES AND MINOR

CHILD

APPELLEES

Opinion Delivered September 30, 2015

APPEAL FROM THE PULASKI

COUNTY CIRCUIT COURT,

EIGHTH DIVISION

[NO. 60JV2014-11]

HONORABLE WILEY A. BRANTON,

JR., JUDGE

AFFIRMED; MOTION TO

WITHDRAW GRANTED

PHILLIP T. WHITEAKER, Judge

O.M. appeals a Pulaski County Circuit Court order terminating her parental rights to

her son D.M. (d/o/b 01/26/2013).1

 O.M.’s attorney has filed a motion to be relieved from

representation and a no-merit brief pursuant to Linker-Flores v. Arkansas Department of Human

Services, 359 Ark. 131, 194 S.W.3d 739 (2004), and Rule 6-9(i) of the Rules of the Arkansas

Supreme Court and Court of Appeals. O.M. was sent a copy of her counsel’s motion and

brief along with a letter informing her of her right to file pro se points for reversal, but the

packet was returned “Attempted-Not Known.” O.M.’s attorney has no additional contact

information for her.

1

 William May is the putative father of D.M. His rights were also terminated by this

order, but he did not file a notice of appeal from that determination; thus, he is not a party

to this appeal. 
Cite as 2015 Ark. App. 528

Having carefully examined the record and the no-merit brief, we conclude that counsel

has complied with the requirements established by the Arkansas Supreme Court for no-merit

appeals in termination cases and that the appeal is wholly without merit. Accordingly, we

affirm by memorandum opinion the termination of O.M.’s parental rights. See In re

Memorandum Opinions, 16 Ark. App. 301, 700 S.W.2d 63 (1985); Ark. Sup. Ct. R. 5-2(e)

(2014). Counsel’s motion to withdraw is granted.

Affirmed; motion to withdraw granted.

GLADWIN, C.J., and HOOFMAN, J., agree.

Leah Lanford, Arkansas Public Defender Commission, for appellant.

No response.

2
xml version="1.0" encoding="UTF-8"?


C\_2021284EN.01001601.xml


| | | | |
| --- | --- | --- | --- |
| 16.7.2021 | EN | Official Journal of the European Union | C 284/16 |

---

Prior notification of a concentration

(Case M.10337 – BC PARTNERS/VISTA EQUITY PARTNERS/EAB GLOBAL)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 284/05)

1.

On 9 July 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2021284EN.01001601-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | BC Partners LLP (‘BC Partners’, United Kingdom), |

| | |
| --- | --- |
| — | Vista Equity Partners Management, LLC (‘Vista’, USA) |

| | |
| --- | --- |
| — | EAB Global, Inc. (‘EAB Global’, USA) |

BC Partners and Vista acquire within the meaning of Articles 3(1)(b) and 3(4)of the Merger Regulation joint control of the whole of EAB Global, which is currently solely controlled by funds managed by Vista.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | for BC Partners: international investment firm providing advisory services to financial investors, |

| | |
| --- | --- |
| — | for Vista: investment firm focused on enterprise software, data and technology-enabled businesses, |

| | |
| --- | --- |
| — | for EAB Global: company providing best practices research, student success management software and data-enabled enrolment solutions to the not-for-profit higher education and K-12 markets. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2021284EN.01001601-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10337 – BC PARTNERS/VISTA EQUITY PARTNERS/EAB GLOBAL

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2021284EN.01001601-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2021284EN.01001601-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---